{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:54:34Z","timestamp":1793141674164,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ard.2026.01.014","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:29:45Z","timestamp":1772022585000},"page":"1425-1435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of mufemilast in patients with Beh\u00e7et\u2019s syndrome: a phase 2 randomised clinical trial"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-8372","authenticated-orcid":false,"given":"Tian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlou","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cibo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuning","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianli","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqi","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wantai","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2590-6242","authenticated-orcid":false,"given":"Zhanguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ard.2026.01.014_bib0001","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","article-title":"Beh\u00e7et syndrome: a contemporary view","volume":"14","author":"Yazici","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.ard.2026.01.014_bib0002","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMra2305712","article-title":"Beh\u00e7et\u2019s syndrome","volume":"390","author":"Saadoun","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ard.2026.01.014_bib0003","first-page":"46","article-title":"What affects the quality of life in patients with Beh\u00e7et\u2019s disease?","volume":"39","author":"Meliko\u011flu","year":"2014","journal-title":"Acta Reumatol Port"},{"issue":"10431","key":"10.1016\/j.ard.2026.01.014_bib0004","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(23)02629-6","article-title":"Beh\u00e7et\u2019s syndrome","volume":"403","author":"Emmi","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ard.2026.01.014_bib0005","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ard.2026.01.014_bib0006","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/FJC.0000000000000773","article-title":"Myocardial phosphodiesterases and their role in cGMP regulation","volume":"75","author":"Dunkerly-Eyring","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"10.1016\/j.ard.2026.01.014_bib0007","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1568026621666210909164118","article-title":"Natural molecules as talented inhibitors of nucleotide pyrophosphatases\/phosphodiesterases (PDEs)","volume":"22","author":"Orhan","year":"2022","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"10.1016\/j.ard.2026.01.014_bib0008","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/ijms23031209","article-title":"Clinical implication of phosphodiesterase-4-inhibition","volume":"23","author":"Schick","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"18","key":"10.1016\/j.ard.2026.01.014_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810616","article-title":"The complexity and multiplicity of the specific cAMP phosphodiesterase family: PDE4, open new adapted therapeutic approaches","volume":"23","author":"Lugnier","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.ard.2026.01.014_bib0010","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1816594","article-title":"Trial of apremilast for oral ulcers in Beh\u00e7et\u2019s syndrome","volume":"381","author":"Hatemi","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ard.2026.01.014_bib0011","doi-asserted-by":"crossref","first-page":"80","DOI":"10.55563\/clinexprheumatol\/ra8ize","article-title":"Apremilast for oral ulcers associated with active Beh\u00e7et\u2019s syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial","volume":"39","author":"Hatemi","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.ard.2026.01.014_bib0012","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s13555-023-00975-3","article-title":"Early discontinuation of apremilast in patients with psoriasis and gastrointestinal comorbidities: rates and associated risk factors","volume":"13","author":"Schmidt","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"10.1016\/j.ard.2026.01.014_bib0013","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ced\/llae284","article-title":"Treatment of Beh\u00e7et disease with oral roflumilast: an observational study","volume":"50","author":"Pe\u00f1uelas Leal","year":"2024","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"10.1016\/j.ard.2026.01.014_bib0014","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1016\/j.cgh.2019.12.032","article-title":"Effects of apremilast, an oral inhibitor of phosphodiesterase 4, in a randomized trial of patients with active ulcerative colitis","volume":"18","author":"Danese","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ard.2026.01.014_bib0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/pharmaceutics17010091","article-title":"Exploring the therapeutic landscape: a narrative review on topical and oral phosphodiesterase-4 inhibitors in dermatology","volume":"17","author":"Carmona-Rocha","year":"2025","journal-title":"Pharmaceutics"},{"issue":"Suppl 9","key":"10.1016\/j.ard.2026.01.014_bib0016","article-title":"A double-blind, placebo-parallel controlled phase III clinical study of the efficacy and safety of Hemay005 tablets in patients with moderate to severe chronic plaque psoriasis in China","volume":"75","author":"Jones","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.ard.2026.01.014_bib0017","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/annrheumdis-2015-207963","article-title":"Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)","volume":"75","author":"Edwards","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ard.2026.01.014_bib0018","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.ard.2026.01.014_bib0019","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/acr.24511","article-title":"Core set of domains for outcome measures in Beh\u00e7et\u2019s syndrome","volume":"74","author":"Hatemi","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ard.2026.01.014_bib0020","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","article-title":"Beh\u00e7et\u2019s disease: evaluation of a new instrument to measure clinical activity","volume":"38","author":"Bhakta","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.ard.2026.01.014_bib0021","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0950-3579(97)80052-0","article-title":"Disease assessment and management of the vasculitides","volume":"11","author":"Luqmani","year":"1997","journal-title":"Baillieres Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.ard.2026.01.014_bib0022","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5","article-title":"Toward a multidimensional health assessment questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format","volume":"42","author":"Pincus","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ard.2026.01.014_bib0023","series-title":"SF-36 Health Survey: manual and interpretation guide","author":"Ware","year":"1993"},{"issue":"5","key":"10.1016\/j.ard.2026.01.014_bib0024","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1586\/ers.10.56","article-title":"Roflumilast for the treatment of chronic obstructive pulmonary disease","volume":"4","author":"Rabe","year":"2010","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"10.1016\/j.ard.2026.01.014_bib0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1476-5381.2011.01218.x","article-title":"Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease","volume":"163","author":"Rabe","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"8697","key":"10.1016\/j.ard.2026.01.014_bib0026","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et\u2019s disease. International Study Group for Beh\u00e7et\u2019s Disease","volume":"335","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ard.2026.01.014_bib0027","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10067-013-2411-3","article-title":"Validation of the revised International Criteria for Behcet\u2019s Disease (ICBD) in Iran","volume":"34","author":"Davatchi","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.ard.2026.01.014_bib0028","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1093\/rheumatology\/keac018","article-title":"Evaluation of sensitivity and specificity of diagnostic criteria for Beh\u00e7et\u2019s disease in the absence of a gold standard","volume":"61","author":"Zhong","year":"2022","journal-title":"Rheumatology (Oxford)"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672600018X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672600018X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:31:40Z","timestamp":1783207900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672600018X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S000349672600018X"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.01.014","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of mufemilast in patients with Beh\u00e7et\u2019s syndrome: a phase 2 randomised clinical trial","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}